| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |